Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9600 posts found.

ICON acquires market access consultancy

February 28, 2012 Research and Development CRO, ICON, pharma market access, pricing and reimbursement

ICON has acquired consulting firm PriceSpective, helping to expand the contract research organisation’s services in the field of pricing and …
News

On-going Medicine evaluation Information to be published by European Medicines Agency

February 24, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates

Following the recommendations on transparency published by the European Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA), …
News
Press release

EMA accepts Genzyme MS drug for review

February 24, 2012 Research and Development, Sales and Marketing EMA, Genzyme, Sanofi, teriflunomide

The European Medicines Agency has accepted Genzyme’s application for its multiple sclerosis pill teriflunomide.  Genzyme, which is wholly owned by …
News
werner_wenning_bayer

Werner Wenning proposed as chairman of the supervisory board at Bayer

February 24, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Bayer, Schneider, Wenning

Former Bayer chief executive Werner Wenning is set to be elected to the supervisory board at Bayer with effect from October. …
Appointment
Genzyme picture

Genzyme to close UK site

February 24, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, UK, job cuts

Genzyme will close its Cambridge R&D site by the end of the year, with a loss of around 60 jobs.  …
News

The NHS, a postcard from the frontline

February 24, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brighton, NHS, Sussex, reforms

It is January 2012, and the NHS in England is under huge strain. This is because it is being asked …
Feature

Astellas hires senior vice president for new Global Medical Affairs organisation

February 24, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing

Astellas has announced that Charlotte Kremer has joined the company as the head of one of the Company’s newest organisations …
Appointment

Alex Gorsky named new chief executive of J&J

February 22, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alex Gorsky, J&J, JJ, Janssen, Weldon

Johnson & Johnson has named Alex Gorsky as its new chief executive, effective from 26 April. Gorsky was also nominated …
Appointment
Takeda image

Takeda’s ulcerative colitis drug gets Phase III boost

February 22, 2012 Research and Development

Takeda’s ulcerative colitis drug vedolizumab has succeeded in a late-stage trial.  The Phase III trial studied vedolizumab in 895 patients …
News
Georg Toufar

Working Life: Georg Toufar, director, Mundipharma

February 21, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Georg Toufar, Mundipharma, Working Life

Georg Toufar is director of European marketing and sales and member of the executive committee at Mundipharma International Limited (MINT).  …
Feature

Bayer eye drug succeeds in long-term study

February 21, 2012 Research and Development, Sales and Marketing Bayer, Lucentis, aflibercept, wet AMD

Bayer’s eye drug aflibercept has succeeded in a long-term study in patients with a common eye condition.  The Phase III …
News

Contract research news in brief

February 21, 2012 Research and Development Almac, GVK Biosciences and PreClinOmics/AIT, PPD, Quintiles

Our round-up of news from the contract research sector includes PPD’s sales to a private equity consortium, new clinical supply …
News

Setback for Gilead hep C candidate

February 20, 2012 Research and Development, Sales and Marketing ELECTRON, GS-7977, Gilead, Pharmasset

Gilead’s investigational hepatitis C drug has been dealt a blow after patients suffer relapses in a mid-stage trial.  In the …
News

Pfizer closes in on $545m China generics deal

February 20, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing China, Hisun, Pfizer, Zhejiang, generics

Pfizer has moved a step closer to a deal with Shanghai-based Zhejiang Hisun Pharmaceutical to develop generic drugs in China.  …
News

Health Information appoints Nigel Brooksby as its deputy chairman

February 20, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Brooksby, Health Information

Health Information, a provider of medicine adherence services in the UK, has appointed former ABPI president Nigel Brooksby as its …
Appointment
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026